Publications by authors named "Dan Douer"

Claim this Profile
O
Optimizing Asparaginase Treatment for Adolescent and Young Adult (AYA) Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations.
Ibrahim Aldoss, Amir Ali, Ryan D Cassaday, Emily K Curran, Marlise R Luskin, Dan Douer

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognition, prevention, and management of adverse events associated with asparaginase/ pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panel.
Emily Curran, Marlise R Luskin, Houda Alachkar, Ibrahim Aldoss, Patrick W Burke, Dan Douer

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic profile of novel reduced-dose Danziten (nilotinib tablets) versus Tasigna (nilotinib capsules): in vivo bioequivalence and population pharmacokinetic analysis.
Michael Mauro, Jerald Radich, Paras Jain, David Sequeira, Francesco Bellanti, Dan Douer

Cancer Chemother Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomes.
Jose Tinajero, Sharon Xu, Dat Ngo, Shanpeng Li, Joycelynne Palmer, Dan Douer

Br J Haematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asparaginase: How to Better Manage Toxicities in Adults.
Hoda Pourhassan, Dan Douer, Vinod Pullarkat, Ibrahim Aldoss

Curr Oncol Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOHO State of the Art Updates and Next Questions | Asparaginase-Understanding and Overcoming Toxicities in Adults with ALL.
Ibrahim Aldoss, Hoda Pourhassan, Dan Douer

Clin Lymphoma Myeloma Leuk· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing use of L-asparaginase-based treatment of adults with acute lymphoblastic leukemia.
Dan Douer, Nicola Gökbuget, Wendy Stock, Nicolas Boissel

Blood Rev· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.
Todd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, Neeta Pandit-Taskar, Mark G Frattini, Dan Douer

Clin Cancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotype of acute lymphoblastic leukemia in minorities- analysis from the SEER database.
Elisa Quiroz, Aparajit Ram Venkateswaran, Rebecca Nelson, Ibrahim Aldoss, Vinod Pullarkat, Dan Douer

Hematol Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials.
Chezi Ganzel, Ju-Whei Lee, Hugo F Fernandez, Elisabeth M Paietta, Selina M Luger, Dan Douer

Blood Adv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Mark B Geyer, Ellen K Ritchie, Arati V Rao, Shreya Vemuri, Jessica Flynn, Dan Douer

Haematologica· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.
Jacob L Glass, Andriy Derkach, Patrick Hilden, Amber King, Susan K Seo, Dan Douer

Leuk Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.
Chezi Ganzel, Xin V Wang, Jacob M Rowe, Susan M Richards, Georgina Buck, Dan Douer

Br J Haematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open-Cancer Horizons roundtable discussion.
Patrick W Burke, Dieter Hoelzer, Jae H Park, Kjeld Schmiegelow, Dan Douer

ESMO Open· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia.
Ibrahim Aldoss, Dan Douer

Blood· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related acute lymphoblastic leukemia: Where do we stand with regards to its definition and characterization?
Ibrahim Aldoss, Dan Douer, Vinod Pullarkat

Blood Rev· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia.
Jeremy Chang, Dan Douer, Ibrahim Aldoss, Golnaz Vahdani, Ah-Reum Jeong

Cancer Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging story of acute lymphoblastic leukemia among the Latin American population - biological and clinical implications.
Elisa Quiroz, Ibrahim Aldoss, Vinod Pullarkat, Eduardo Rego, Guido Marcucci, Dan Douer

Blood Rev· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens.
Stuart E Siegel, Anjali Advani, Nita Seibel, Lori Muffly, Wendy Stock, Dan Douer

Am J Hematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial.
Gary J Schiller, Lloyd E Damon, Steven E Coutre, Pamela Hsu, Gajanan Bhat, Dan Douer

J Adolesc Young Adult Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience.
Chezi Ganzel, Zhuoxin Sun, Larry D Cripe, Hugo F Fernandez, Dan Douer

Am J Hematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.
Stuart E Siegel, Wendy Stock, Rebecca H Johnson, Anjali Advani, Lori Muffly, Dan Douer

JAMA Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses.
Patrick W Burke, Ibrahim Aldoss, Matthew A Lunning, Sean M Devlin, Martin S Tallman, Dan Douer

Leuk Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia.
Peter G Maslak, Tao Dao, Yvette Bernal, Suzanne M Chanel, Rong Zhang, Dan Douer

Blood Adv· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Chromosomal Rearrangement upon DNA Methylation Patterns in Leukemia.
Hyang-Min Byun, Shahrooz Eshaghian, Dan Douer, Jonathen Trent, Guillermo Garcia-Manero

Open Med (Wars)· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis